Thrombolysis for stroke: defining the time window.
Davis
Stephen M
SM
Donnan
Geoffrey A
GA
D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000592:standards*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D010959:Tissue Plasminogen Activator